Reversible dementia during valproate therapy;Reversibele dementie bij gebruik van valproinezuur

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 8, 1997, Pages 391-393

  Walstra, G J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

AGED; ARTICLE; CASE REPORT; DEMENTIA; DRUG WITHDRAWAL; FEMALE; HUMAN;

AGED; ANTICONVULSANTS; DEMENTIA; EPILEPSY, TONIC-CLONIC; FEMALE; FRONTAL LOBE; HUMANS; VALPROIC ACID;

EID: 0031046364     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Weytingh MD, Bossuyt PMM, Crevel H van. Reversible dementia: more than 10% or less than 1%? A quantitative review. J Neurol 1995;242:466-71.
2. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. (DSM IV). Washington, DC: APA, 1994.
3. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-8.
4. Cummings JL, Benson DF. Dementia: definition, prevalence, classification, and approach to diagnosis. In: Cummings JL, Benson DF, editors. Dementia. A clinical approach. Boston: Butterworth, 1992: 9-17.
5. Cummings JL, Benson DF. Laboratory aids in the diagnosis of dementia. In: Cummings JL, Benson DF, editors. Dementia. A clinical approach. Boston: Butterworth, 1992:357-60.
6. Centraal Begeleidings Orgaan voor de Intercollegiale Toetsing (CBO). Diagnostiek bij het dementiesyndroom. Utrecht: CBO, 1988:4-5.
7. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37:121-30.
8. Timmings PL, Richens A. Neurotoxicology of anti-epileptic drugs. In: Wolff FA de, editor. Handbook of clinical neurology, vol 21 (65): Intoxications of the nervous system. Part II. Amsterdam: Elsevier, 1995:503-5.
9. Papazian O, Canizales E, Alfonso I, Archila R, Duchowny M, Aicardi J. Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 1995;38:687-91.
10. Zaret BS, Cohen RA. Reversible valproic acid-induced dementia: a case report. Epilepsia 1986;27:234-40.
11. McLachlan RS. Pseudoatrophy of the brain with valproic acid monotherapy. Can J Neurol Sci 1987;14:294-6.
12. Bentson J, Reza M, Winter J, Wilson G. Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr 1978;2:16-23.
13. Cummings JL, Benson DF. Dementia in metabolic disturbances and toxic conditions. In: Cummings JL, Benson DF, editors. Dementia. A clinical approach. Boston: Butterworth, 1992:249-57.
14. Arnold SE, Kumar A. Reversible dementias. Med Clin North Am 1993;77:215-30.
15. Centraal Begeleidings Orgaan voor de Intercollegiale Toetsing (CBO). Diagnostiek bij het dementiesyndroom. Utrecht: CBO, 1988:13-4.